Individualized Dietary Intervention in Breastfeeding Women: Body Weight and Vitamin A Stores
NCT03640104
Avitaminosis, Behavior
Hermosillo, Sonora, Mexico
View Trial DetailsNCT Number: NCT02220413
The purpose of this study is to investigate what proportion of obese women will have a self-reported delay in lactogenesis II ("breastmilk coming in") compared to women with a normal weight. We hypothesize that obese women will have an absolute 20% increase in delayed lactogenesis II.
We will compare two group of women for delayed lactogenesis II, one group with obese women (BMI>30) and one group of women with a normal weight (BMI<30).
The secondary objective is to assess what other factors influence the self-reported delayed lactogenesis II.
Looking for future studies?
Notify Me18 year–50 year
Female
Observational
TGH Health Park Genesis Clinic, Tampa, Florida, United States
Lactogenesis I occurs during pregnancy (midpregnancy and beyond), when the mammary glands becomes sufficiently differentiated to secrete small quantities of specific milk components. Lactogenesis II is defined as the onset of plentiful milk secretion and typically occurs between 30-40 hours post delivery. It is typically described by women as a sense of fullness and leakage of milk which is subjectively reported between 50-73 hours post delivery. The incidence of delayed lactogenesis II ranges from 17-44%.
The risk of neonatal weight loss is up to 7 times greater for exclusively breastfed infants of women who experience delayed lactogenesis II as compared to women who experience typical onset lactogenesisII. In a qualitative study of 114 lactating women, increasing BMI was significantly associated with maternal perceptions of delayed onset of lactogenesis II.
The United States Breastfeeding Committee supports exclusive breastfeeding for the first 6 months of life because it "may exert a small but positive influence in reducing the risk of obesity in childhood and later in life…" Breastfeeding has also been associated with decreased risk of maternal morbidities such as type 2 diabetes, subclinical cardiovascular disease and less abdominal visceral adiposity. Given that prolonged breastfeeding improves the overall health of the mother infant dyad, it is critical to obtain a better understanding of those factors predictive of successful breastfeeding outcomes.
At University of South Florida our clinics serve an ethnically diverse population which would benefit from directed efforts at improving breastfeeding. Before we can undertake such a plan we need to assess the contemporary factors impacting lactogenesis.
We plan to prospectively enroll 186 pregnant women into a protocol to examine factors associated with delayed lactogenesis. Ninety-three women will have a BMI of 30 or higher at the time of delivery and the other 93 women will have a BMI ≤ 29 at the time of delivery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2-5 days post delivery
Women will be asked about the perception of the onset of their breastmilk coming such as breast engorgement.
Time frame: Six weeks post delivery
Women presenting for their 6 week postpartum exam will be asked to complete a short interview of 4 questions in regards to breastfeeding duration, "Measurement of intensity of breastfeeding behavior". Exclusivity of breastfeeding will be based on Labbok's suggested levels of breastfeeding behaviors.Women will be asked "How is your infant feeding? Why?" Responses will be categorized into exclusive, almost exclusive, partial high, partial low, token or no breastfeeding. Women not currently breastfeeding will be asked when the infant last received any breast milk and what the reason is for stop breastfeeding. If we miss the patient at their postpartum visit, we will complete the questionnaire by telephone.
University of South Florida
Other
Predictors and Moderators of Delayed Lactogenesis II and Duration of Breastfeeding
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03640104
Avitaminosis, Behavior
Hermosillo, Sonora, Mexico
View Trial DetailsNCT02756169
Behavior, Body Weight
Mexico City, Mexico
View Trial DetailsNCT06975527
Behavior, Breast Feeding
Beheira, Egypt
View Trial DetailsNCT07724509
Behavior, Breast Feeding
Niğde, Merkez, Turkey (Türkiye)
View Trial Details